NeuralStem

United States
Barbourmeade, Kentucky, United States, 20850

Company profile

NeuralStem company profile

Neuralstem, Inc. is a publicly traded biotherapeutics company. The company aims to apply "stem cell research and its patented human neural stem cell technology to treat diseases of the central nervous system including Ischemic Paraplegia, Traumatic Spinal Cord Injury, ALS and Parkinson’s Disease." Neuralstem's research has allowed them to produce mature, commercial quantities of neural stem cells that can be transplanted into humans as treatments for currently incurable diseases.

Business identity

Phone number
+30136649606
Operating status
Closed
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
1996-01-01, Year

Headquarters

Postal code
20850
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
6
Total equity funding
$31.9M
Last funding
Post IPO Equity / $7.5M / 2019-07-31
Last equity funding
Post IPO Equity / $7.5M
Investors
2
Lead investors
1
Founders
1
Articles
7
Exited on
2019-11-01

Founders and investors

Founders

I. Richard Garr

Lead investors

Tianjin Pharmaceutical Group International Holdings

Investors

Hercules CapitalTianjin Pharmaceutical Group International Holdings